APLT 241220 7.50P (APLT241220P7500) Stock Options, News & Quotes

US OptionsDetailed Quotes

APLT241220P7500

Watchlist

1.40
+0.25+21.74%

15min DelayTrading Nov 27 11:59 ET

1.43High1.05Low

Intraday

5D
Daily

News

Baird Maintains Applied Therapeutics(APLT.US) With Buy Rating, Maintains Target Price $14
Moomoo NewsNov 21 02:32 ET · Ratings
Positive Regulatory Outlook and Imminent PDUFA Date Justify Buy Rating for Applied Therapeutics
TipRanksNov 11 01:29 ET · Ratings
RBC Capital Maintains Applied Therapeutics(APLT.US) With Buy Rating, Maintains Target Price $12
Moomoo NewsNov 8 21:32 ET · Ratings
Applied Therapeutics Advances With Govorestat Approvals
TipRanksNov 8 00:59 ET
Applied Therapeutics (APLT) Gets a Buy From William Blair
TipRanksNov 7 09:07 ET · Ratings
Applied Therapeutics Reports Q3 EPS (48c), Consensus (16c)
TipRanksNov 7 07:44 ET

Comments

Meltyy

Nov 26 01:17

🚨 1 PDUFA this week!

See FDA PDUFA update 👇
$Applied Therapeutics (APLT.US)$ : 🤔
⇨ Govorestat
‣ Classic Galactosemia
‣ PDUFA: 11/28/24 (NDA)
🗓️ Last Week’s Adcom & PDUFA decisions:
$BridgeBio Pharma (BBIO.US)$ : Approved 11/22 ✅
⇨Attruby (Acoramidis)
‣ ATTR-CM (transthyretin amyloid cardiomyopathy)
‣ PDUFA: 11/29/24 (NDA)
$AstraZeneca (AZN.US)$ : Discussion, no vote
⇨ Andexxa (coagulation factor Xa)
‣ Life-threatening or uncontrolled bleeding
‣ Adcom: 11/21/24 (sBLA)
$Jazz Pharmaceuticals (JAZZ.US)$ & $Zymeworks (ZYME.US)$ : Approve...

frogoracletrading

Oct 21 16:55

$APLT Support / Resistance Levels

Continuing to consolidate over 8.49. Support is now 8.90. If that holds watch for a test of the previous high at 9.32.
Larger Image: tradingview.com...
$Applied Therapeutics (APLT.US)$

Jsmooth420365

Oct 16 07:36

$Applied Therapeutics (APLT.US)$ what a comeback yesterday. thought it was going to finish red. good job bulls!! 👏

Jsmooth420365

Oct 14 17:35

$Applied Therapeutics (APLT.US)$ nice! don't like the big wick on daily tho..

Jsmooth420365

Oct 13 19:03

$Applied Therapeutics (APLT.US)$ cup and handle on weekly.. looking nice. watching for more buyers at this level 👀